6VPF
Estrogen Receptor Alpha Ligand Binding Domain in Complex with the Selective Estrogen Receptor Modulator Clomiphene
Summary for 6VPF
Entry DOI | 10.2210/pdb6vpf/pdb |
Descriptor | Estrogen receptor, Clomifene (3 entities in total) |
Functional Keywords | breast cancer, hormone, selective estrogen receptor modulator, antiestrogen, alpha helical bundle, transferase |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 4 |
Total formula weight | 122412.64 |
Authors | Fanning, S.W.,Greene, G.L. (deposition date: 2020-02-03, release date: 2020-09-16, Last modification date: 2023-10-11) |
Primary citation | Hosfield, D.J.,Weber, S.,Li, N.S.,Suavage, M.,Joiner, C.F.,Hancock, G.R.,Sullivan, E.A.,Ndukwe, E.,Han, R.,Cush, S.,Laine, M.,Mader, S.C.,Greene, G.L.,Fanning, S.W. Stereospecific lasofoxifene derivatives reveal the interplay between estrogen receptor alpha stability and antagonistic activity in ESR1 mutant breast cancer cells. Elife, 11:-, 2022 Cited by PubMed: 35575456DOI: 10.7554/eLife.72512 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.6 Å) |
Structure validation
Download full validation report